Characterization of a metabolomics signature of the brain-health-promoting MIND diet in older persons.

IF 7.8 Q2 BUSINESS
Jeanne Neuffer, Raúl González-Domínguez, Sophie Lefèvre-Arbogast, Dorrain Y Low, Alba Tor-Roca, Catherine Helmer, Andrea Du Preez, Chiara de Lucia, Silvie R Ruigrok, Barbara Altendorfer, Ludwig Aigner, Paul J Lucassen, Aniko Korosi, Sandrine Thuret, Claudine Manach, Mercè Pallàs, Alex Sánchez-Pla, Cristina Andres-Lacueva, Mireia Urpi-Sarda, Cécilia Samieri
{"title":"Characterization of a metabolomics signature of the brain-health-promoting MIND diet in older persons.","authors":"Jeanne Neuffer, Raúl González-Domínguez, Sophie Lefèvre-Arbogast, Dorrain Y Low, Alba Tor-Roca, Catherine Helmer, Andrea Du Preez, Chiara de Lucia, Silvie R Ruigrok, Barbara Altendorfer, Ludwig Aigner, Paul J Lucassen, Aniko Korosi, Sandrine Thuret, Claudine Manach, Mercè Pallàs, Alex Sánchez-Pla, Cristina Andres-Lacueva, Mireia Urpi-Sarda, Cécilia Samieri","doi":"10.1016/j.tjpad.2026.100670","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The MIND diet supports healthy cognitive aging. Yet, a challenge remains to identify individuals who do not adhere to the MIND and could be at risk for accelerated cognitive decline. A multi-metabolite biomarker panel could facilitate population screening.</p><p><strong>Objectives: </strong>To determine and validate a blood metabolomics signature of MIND adherence in a large cohort of older adults, and to estimate its association with subsequent cognitive decline.</p><p><strong>Design, setting and participants: </strong>Participants were older adults (≥65 years) from the population-based three-City (3C) cohort, free of dementia at study baseline and followed for up to 12 years for cognition, who were included in two case-control samples on cognitive decline nested within two centers (Bordeaux and Dijon cities, n = 838).</p><p><strong>Exposures: </strong>155 diet-related serum metabolites measured with a multianalyte metabolomics platform.</p><p><strong>Main outcomes and measurements: </strong>The primary outcome was adherence to the MIND diet, assessed in a subsample of 344 participants from Bordeaux center (which underwent the dietary surveys, 24 h recall and food-frequency questionnaire). A metabolomics signature of MIND diet adherence was characterized with penalized regression and a metabolomics score (\"metaboscore\") reflecting the overall MIND biological fingerprint was calculated. The secondary outcome was cognitive decline status (coded as binary: accelerated, vs. null or minimal decline) over follow-up, assessed using repeated cognitive measures in the two case-control samples. The metaboscore was reconstructed and linked to the odds of cognitive decline.</p><p><strong>Results: </strong>Eight metabolites were identified: three were associated with higher MIND adherence (3-hydroxyhippuric acid, 5-hydroxyindole-3-acetic acid, betaine - phenolic acids and amino acid related to plant foods) and five with lower MIND adherence (1-methylhistidine from red meat; cyclo(L-leucyl-L-prolyl) from coffee; tartaric acid from wine; myristoyl-carnitine and dehydroepiandrosterone sulfate, endogenous). The French-MIND metaboscore was linked to lower odds of cognitive decline, although replication was not statistically significant after multivariable adjustment.</p><p><strong>Conclusion: </strong>A novel metabolomic signature of the MIND diet was characterized, which may help screen older adults at risk of poor brain nutrition and could support personalized dietary prevention strategies.</p>","PeriodicalId":22711,"journal":{"name":"The Journal of Prevention of Alzheimer's Disease","volume":"13 10","pages":"100670"},"PeriodicalIF":7.8000,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13586864/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Prevention of Alzheimer's Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.tjpad.2026.100670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BUSINESS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The MIND diet supports healthy cognitive aging. Yet, a challenge remains to identify individuals who do not adhere to the MIND and could be at risk for accelerated cognitive decline. A multi-metabolite biomarker panel could facilitate population screening.

Objectives: To determine and validate a blood metabolomics signature of MIND adherence in a large cohort of older adults, and to estimate its association with subsequent cognitive decline.

Design, setting and participants: Participants were older adults (≥65 years) from the population-based three-City (3C) cohort, free of dementia at study baseline and followed for up to 12 years for cognition, who were included in two case-control samples on cognitive decline nested within two centers (Bordeaux and Dijon cities, n = 838).

Exposures: 155 diet-related serum metabolites measured with a multianalyte metabolomics platform.

Main outcomes and measurements: The primary outcome was adherence to the MIND diet, assessed in a subsample of 344 participants from Bordeaux center (which underwent the dietary surveys, 24 h recall and food-frequency questionnaire). A metabolomics signature of MIND diet adherence was characterized with penalized regression and a metabolomics score ("metaboscore") reflecting the overall MIND biological fingerprint was calculated. The secondary outcome was cognitive decline status (coded as binary: accelerated, vs. null or minimal decline) over follow-up, assessed using repeated cognitive measures in the two case-control samples. The metaboscore was reconstructed and linked to the odds of cognitive decline.

Results: Eight metabolites were identified: three were associated with higher MIND adherence (3-hydroxyhippuric acid, 5-hydroxyindole-3-acetic acid, betaine - phenolic acids and amino acid related to plant foods) and five with lower MIND adherence (1-methylhistidine from red meat; cyclo(L-leucyl-L-prolyl) from coffee; tartaric acid from wine; myristoyl-carnitine and dehydroepiandrosterone sulfate, endogenous). The French-MIND metaboscore was linked to lower odds of cognitive decline, although replication was not statistically significant after multivariable adjustment.

Conclusion: A novel metabolomic signature of the MIND diet was characterized, which may help screen older adults at risk of poor brain nutrition and could support personalized dietary prevention strategies.

老年人脑健康促进饮食的代谢组学特征
背景:MIND饮食支持健康的认知衰老。然而,一个挑战仍然是识别那些不坚持心智的人,他们可能有加速认知能力下降的风险。多代谢物生物标志物面板可以促进人群筛查。目的:在一大批老年人中确定并验证MIND依从性的血液代谢组学特征,并估计其与随后的认知能力下降的关联。设计、环境和参与者:参与者是来自以人口为基础的三城市(3C)队列的老年人(≥65岁),在研究基线时无痴呆,认知能力随访长达12年,他们被纳入两个中心(波尔多和第戎城市,n = 838)的两个认知能力下降病例对照样本。暴露:用多分析物代谢组学平台测量155种与饮食相关的血清代谢物。主要结果和测量:主要结果是对MIND饮食的依从性,在波尔多中心的344名参与者的子样本中进行了评估(他们接受了饮食调查、24小时回忆和食物频率问卷)。通过惩罚回归对MIND饮食依从性的代谢组学特征进行表征,并计算反映总体MIND生物指纹的代谢组学评分(“metaboscore”)。次要结局是随访期间的认知衰退状态(编码为二进制:加速,vs.零或最小程度的下降),在两个病例对照样本中使用重复的认知测量来评估。代谢分数被重建,并与认知能力下降的几率联系起来。结果:鉴定出8种代谢物:3种与较高的MIND依存性相关(3-羟基马尿酸、5-羟基吲哚-3-乙酸、甜菜碱-酚酸和与植物性食物相关的氨基酸),5种与较低的MIND依存性相关(红肉中的1-甲基组氨酸、咖啡中的环(l-亮氨酸-l -脯氨酸);酒中的酒石酸;肉豆蔻酰基肉碱和硫酸脱氢表雄酮,内源性)。French-MIND代谢评分与认知能力下降的几率较低有关,尽管在多变量调整后,重复性没有统计学意义。结论:MIND饮食的一种新的代谢组学特征被表征出来,这可能有助于筛选有脑营养不良风险的老年人,并可能支持个性化的饮食预防策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
The Journal of Prevention of Alzheimer's Disease
The Journal of Prevention of Alzheimer's Disease Medicine-Psychiatry and Mental Health
CiteScore
9.20
自引率
0.00%
发文量
0
期刊介绍: The JPAD Journal of Prevention of Alzheimer’Disease will publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.JPAD will publish also the meeting abstracts from Clinical Trial on Alzheimer Disease (CTAD) and will be distributed both in paper and online version worldwide.We hope that JPAD with your contribution will play a role in the development of Alzheimer prevention.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书